Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04931095 · ClinicalTrials.gov registry record · Phase 1

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

A Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT04931095 is a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication that has completed, run by Johns Hopkins University. The registered enrollment target is 60 participants, below the 344-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04931095, a Phase 1 study of Alcohol Intoxication and Cannabis Intoxication, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.

Interventions

  • DRUG Alcohol
  • DRUG Cannabis

Study Locations (1)

Maryland

  • Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-02-17
Est. Completion 2025-08-15
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT04931095

The ClinicalTrials.gov registry entry for NCT04931095 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 344-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (83% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Intoxication appearing as the primary indexed condition, and to 2 interventions - of which Alcohol is the first listed.

NCT04931095 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04931095 about?

NCT04931095 is a clinical study titled "The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment". This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.

What is the current status of trial NCT04931095?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2022-02-17. Estimated completion is 2025-08-15.

What conditions does trial NCT04931095 study?

This clinical trial studies the following conditions: Alcohol Intoxication, Cannabis Intoxication.

What interventions are being tested in trial NCT04931095?

The interventions under investigation include: Alcohol (DRUG), Cannabis (DRUG).

Who is sponsoring clinical trial NCT04931095?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04931095 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Intoxication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.